Overview

GS3-007a Oral Solution in Healthy Subjects

Status:
Recruiting

Trial end date:
2023-07-20

Target enrollment:

Participant gender:

Summary

To evaluate the safety and tolerability of GS3-007A in single, multiple, and single oral administration after high-fat meals in Chinese healthy adults.

Phase:

Phase 1

Details

Lead Sponsor:

GeneScience Pharmaceuticals Co., Ltd.